Cargando…

Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract

Immunization with current acellular pertussis (aP) vaccines protects against severe pertussis, but immunity wanes rapidly after vaccination and these vaccines do not prevent nasal colonization with Bordetella pertussis. Studies in mouse and baboon models have demonstrated that Th1 and Th17 responses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chasaide, Caitlín Ní, Mills, Kingston H.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711671/ https://www.ncbi.nlm.nih.gov/pubmed/33096737 http://dx.doi.org/10.3390/vaccines8040621

Ejemplares similares

Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells: A Novel Strategy for Evasion of Protective T Helper Type 1 Responses by Bordetella pertussis
por: McGuirk, Peter, et al.
Publicado: (2002)

Roads to the development of improved pertussis vaccines paved by immunology
por: Brummelman, Jolanda, et al.
Publicado: (2015)

Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
por: Diallo, Béré K., et al.
Publicado: (2023)

Atypical Disease after Bordetella pertussis Respiratory Infection of Mice with Targeted Disruptions of Interferon-γ Receptor or Immunoglobulin μ Chain Genes
por: Mahon, Bernard P., et al.
Publicado: (1997)

Immunization with whole cell but not acellular pertussis vaccines primes CD4 T(RM) cells that sustain protective immunity against nasal colonization with Bordetella pertussis
por: Wilk, Mieszko M., et al.
Publicado: (2019)

A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
por: Zurita, María Eugenia, et al.
Publicado: (2019)

The role of the immune system in driving neuroinflammation
por: Ní Chasaide, Caitlín, et al.
Publicado: (2020)

Next Generation Sequencing Approaches to Characterize the Respiratory Tract Virome
por: Sandybayev, Nurlan, et al.
Publicado: (2022)

Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine
por: Ross, Pádraig J., et al.
Publicado: (2013)

IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F(+) neutrophils
por: Borkner, Lisa, et al.
Publicado: (2021)

Modeling the catarrhal stage of Bordetella pertussis upper respiratory tract infections in mice
por: Soumana, Illiassou H., et al.
Publicado: (2022)

Correction: IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F(+) neutrophils
por: Borkner, Lisa, et al.
Publicado: (2021)

Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.
por: Minagawa, H., et al.
Publicado: (1990)

Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
por: Dotiwala, Farokh, et al.
Publicado: (2023)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

The Diagnostic Value of Metagenomic Next–Generation Sequencing in Lower Respiratory Tract Infection
por: Zheng, Yan, et al.
Publicado: (2021)

Vaccination and Pertussis
por: Fink, Lawrence G.
Publicado: (1908)

Co-detection of Bordetella pertussis and other respiratory organisms in children hospitalised with lower respiratory tract infection
por: Muloiwa, Rudzani, et al.
Publicado: (2020)

A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis
por: Sutton, Caroline, et al.
Publicado: (2006)

Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017)

Distribution Patterns of Pathogens Causing Lower Respiratory Tract Infection Based on Metagenomic Next-Generation Sequencing
por: Chai, Shukun, et al.
Publicado: (2023)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
por: Gregg, Kelsey A., et al.
Publicado: (2019)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

Role of influenza vaccine during pregnancy in protecting against pertussis
por: Nunes, Marta C., et al.
Publicado: (2018)

Azithromycin Clears Bordetella pertussis Infection in Mice but Also Modulates Innate and Adaptive Immune Responses and T Cell Memory
por: Borkner, Lisa, et al.
Publicado: (2018)

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
por: Harper, Diane M., et al.
Publicado: (2011)

Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing
por: Bittinger, Kyle, et al.
Publicado: (2014)

Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections
por: Diao, Zhenli, et al.
Publicado: (2021)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
por: Morens, David M., et al.
Publicado: (2023)

Study on Toxicity Reduction and Potency Induction in Whole-cell Pertussis Vaccine by Developing a New Optimal Inactivation Condition Processed on Bordetella pertussis
por: Mohammadpour Dounighi, Naser, et al.
Publicado: (2016)

Next generation vaccines
Publicado: (2014)

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria
por: Tahar djebbar, Khedidja, et al.
Publicado: (2022)

Lack of Cross-protection against Bordetella holmesii after Pertussis Vaccination
por: Zhang, Xuqing, et al.
Publicado: (2012)

COVID-19 in children: Could pertussis vaccine play the protective role?
por: Ismail, Mohamad Bachar, et al.
Publicado: (2020)

Could Bordetella pertussis vaccine protect against coronavirus COVID-19?
por: Alkholy, Usama M., et al.
Publicado: (2020)

Diagnostic limitations of clinical case definitions of pertussis in infants and children with severe lower respiratory tract infection
por: Muloiwa, Rudzani, et al.
Publicado: (2020)

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
por: Gao, Jingjing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_msp7tvvsrm40ja2hee7oa4h3m1